Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1309 participants
OBSERVATIONAL
2017-09-30
2021-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To this end, a national network of sarcoma treatment specialists and a structure for patient recruitment will be established. This care network is intended to reflect the current situation of the treatment of sarcoma patients in Germany.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
QUEST: QUality of Life and Experiences of Sarcoma Trajectories
NCT03441906
Treatment Patterns and Outcomes in Participants With Advanced Melanoma in Germany Using a German Database
NCT05426239
Patient Reported Outcome Measures After Treatment of Skin Cancers on the Face
NCT04485442
Study in Patients With Solid Tumor Regarding Access to Dermo-cosmetics and Aesthetic Solutions
NCT05907551
Tracing Dissemination of Melanoma Cells in Healthy Tissues
NCT02854124
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* not able to till out questionaires in German
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Technische Universität Dresden
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Markus Schuler
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Markus Schuler, MD
Role: PRINCIPAL_INVESTIGATOR
Technical University Dresden, Medical Faculty
Jochen Schmitt, PhD
Role: PRINCIPAL_INVESTIGATOR
Technical University Dresden, Medical Faculty
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Dresden
Dresden, Saxony, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Eichler M, Hentschel L, Singer S, Hornemann B, Hohenberger P, Kasper B, Andreou D, Pink D, Jakob J, Arndt K, Kirchberg J, Richter S, Bornhauser M, Schmitt J, Schuler MK. Distress in soft-tissue sarcoma and gastrointestinal stromal tumours patients-Results of a German multicentre observational study (PROSa). Psychooncology. 2022 Oct;31(10):1700-1710. doi: 10.1002/pon.6009. Epub 2022 Aug 18.
Related Links
Access external resources that provide additional context or updates about the study.
study site with information for participating patients and about recruiting study centers (in German)
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
111713
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.